| Income Statement |
| Total Revenue | 26.52M |
|
| Revenues (USD) | 26.52M |
| Gross Profit | 26.52M |
| Operating Expenses | 39.82M |
| Research and Development Expense | 29.54M |
| Selling, General and Administrative Expense | 10.29M |
| Operating Income | -13.30M |
| Income Tax Expense | 337.00K |
| Net Income | -8.64M |
| Net Income Common Stock | -8.64M |
| Net Income Common Stock (USD) | -8.64M |
| Consolidated Income | -8.64M |
| Earnings per Basic Share | -0.19 |
| Earnings per Basic Share (USD) | -0.19 |
| Earnings per Diluted Share | -0.19 |
| Earning Before Interest & Taxes (EBIT) | -8.30M |
| Earning Before Interest & Taxes (USD) | -8.30M |
| Weighted Average Shares | 44.76M |
| Weighted Average Shares Diluted | 44.76M |
| Balance Sheet |
| Cash and Equivalents | 72.51M |
| Cash and Equivalents (USD) | 72.51M |
| Investments | 450.49M |
| Investments Current | 275.80M |
| Investments Non-Current | 174.69M |
| Trade and Non-Trade Receivables | 10.84M |
| Current Assets | 368.06M |
| Property, Plant & Equipment Net | 25.26M |
| Total Assets | 569.69M |
| Debt Current | 2.31M |
| Total Debt | 23.09M |
| Current Liabilities | 78.17M |
| Debt Non-Current | 20.78M |
| Total Liabilities | 191.23M |
| Accumulated Retained Earnings (Deficit) | -175.89M |
| Accumulated Other Comprehensive Income | -569.00K |
| Shareholders Equity | 378.46M |
| Shareholders Equity (USD) | 378.46M |
| Assets Non-Current | 201.63M |
| Total Debt (USD) | 23.09M |
| Deferred Revenue | 151.95M |
| Liabilities Non-Current | 113.07M |
| Trade and Non-Trade Payables | 7.46M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 987.00K |
| Net Cash Flow from Financing | 333.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -49.12M |
| Capital Expenditure | -832.00K |
| Issuance (Purchase) of Equity Shares | 333.00K |
| Net Cash Flow from Investing | -23.82M |
| Net Cash Flow - Investment Acquisitions and Disposals | -22.98M |
| Net Cash Flow from Operations | -25.63M |
| Share Based Compensation | 6.02M |